ARTICLE | Finance
BioCentury’s final Public Equity Report of the year tallies up fundraising activity
By Paul Bonanos, Director of Biopharma Intelligence, and Director of Research Meredith Durkin Wolfe
December 31, 2024 11:18 PM UTC
Despite the holiday season, PIPE deals in the past two weeks maintained this year’s brisk pace, with six companies raising $50 million or more since Dec. 15. Follow-ons, however, dried up, with none crossing the $50 million mark. But both the PIPE and follow-on categories are closing out 2024 with a rise in both deal volume and dollars raised, compared with 2023, particularly for the former financing vehicle.
BioCentury’s BCIQ database recorded 107 PIPE deals in 2024 that were worth at least $50 million, totaling $15.5 billion. That’s an increase from 57 such deals, worth $8.3 billion, last year…
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/654548/biotech-raises-make-2024-the-year-of-the-pipe